Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 6-K Current report (foreign)
- 99.1 Notice and Proxy Statement with Respect to the Company's Annual General Meeting of Shareholders
- 99.2 Proxy Card for Holders of Ordinary Shares with Respect to the Company's Annual General Meeting of Shareholders
- 99.3 Voting Instruction Card for American Depositary Share Holders with Respect to the Company's Annual General Meeting of Shareholders
CANF similar filings
- 1 Jun 21 Report of Foreign Private Issuer
- 27 May 21 Can-Fite Reports First Quarter 2021 Financial Results & Provides Clinical Update
- 29 Apr 21 Can-Fite’s Phase III Psoriasis Study Achieves 75% Enrollment; Top Line Results Expected Q4 2021
- 23 Apr 21 Report of Foreign Private Issuer
- 22 Apr 21 Report of Foreign Private Issuer
- 20 Apr 21 Can-Fite Initiates Preclinical Studies Required by FDA and EMA for the Registration of its Two Lead Drug Candidates
- 5 Apr 21 Patent applications filed to protect discovery of cannabinoid-based therapies where the A3AR target is overexpressed including liver cancer
Filing view
External links